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EDITORIAL
Sleep apnea in focus
A apneia do sono em foco
Obstructive sleep apnea (OSA) is characterized by repetitive 
episodes of partial or complete upper airway obstruction 
during sleep. The immediate or primary consequences of 
OSA occurs during sleep and include cyclic asphyxia (i.e. 
decreases in arterial oxygen + increases in arterial CO2), 
generation of excessive negative intrathoracic pressure 
against the occluded airways and fragmented sleep. 1 The 
daytime symptoms that may accompany OSA are multiple 
and include excessive daytime somnolence, tiredness, loss 
of quality of life and loss of memory. OSA may trigger a 
cascade of intermediate mechanisms that are potentially 
harmful to the cardiovascular and metabolic system, and 
include sympathetic over activity, systemic infl ammation, 
alterations in blood pressure control, insulin resistance, 
endothelial dysfunction and atherosclerosis. 2-4 OSA 
may trigger or contribute to several diseases, including 
hypertension, diabetes and cardiac arrhythmias. All these 
intermediate mechanisms may help to explain the increased 
mortality associated with OSA that can be reverted with the 
treatment with continuous positive airway pressure (CPAP). 5 
The prevalence of OSA in the general population varies 
according to the disease criteria and technology used to 
detect respiratory events. One recent epidemiologic study 
in the city of São Paulo, Brazil, found that OSA syndrome 
according to current guidelines (i.e. apnea hypopnea 
index –AHI > 5 events/h plus symptoms or AHI > 15 events/h 
independent of symptoms) was 32.8 %. 6 Despite the high 
prevalence of OSA and the several consequences if left 
untreated, it is estimated that 85 % of the patients are 
not diagnosed. 2 In this issue of the Portuguese Journal of 
Pulmonology, 2 fundamental aspects of OSA regarding 
diagnosis and treatment were reported and deserves close 
attention.
The search for questionnaires that will help to diagnose 
OSA remains a major challenge in the field. The Berlin 
questionnaire is a popular one used to screen and stratify 
patients in low and high risk for OSA and is based on 
questions organized in 3 categories related to snoring and 
witnessed apneas, daytime tiredness and the presence of 
hypertension or obesity. Patients who are positive in at least 
2 categories are considered as having high risk for OSA. 7 The 
Berlin questionnaire has been validated and is used in Brazil 
to estimate the prevalence of OSA among truck drivers. 8,9 
It is important to note that the Portuguese language from 
Portugal and from Brazil do present several different 
expressions. For instance the words used for snoring in 
Portugal and Brazil are different. Therefore the validation 
of the questionnaire in Portugal is imperative. In the fi rst 
study, Vaz et al have validated the Berlin Questionnaire 
to the Portuguese language by using back translation 
methodology. 10 In addition the authors have prospectively 
applied the questionnaire to 95 consecutive subjects referred 
to sleep centre with suspected OSA. The authors concluded 
that being in the high risk group was not a good predictor 
of OSA and that therefore the Berlin questionnaire is not an 
appropriate screening tool for a high risk population such 
as the patients referred to a sleep laboratory. Therefore, 
for patients with a high pre test probability of OSA, the 
questionnaire may add little information. We have recently 
evaluated the characteristics and clinical predictors of 
OSA in a series of 99 consecutive patients followed up in 
a hypertension unit. 11 The clinical parameters included 
age, gender, obesity, daytime sleepiness, snoring, Berlin 
Questionnaire, resistant hypertension, and metabolic 
syndrome. The Berlin Questionnaire revealed a high 
sensitivity but a low specifi city to predict OSA. The common 
theme that arises from these studies is that several patients 
with OSA do not present the so called “typical” symptoms.
In another provocative study by Loureiro et al. published 
in this issue of the Portuguese Journal of Pulmonology, 
the authors described a case series of patients with OSA 
and hypertension that presented a rise in blood pressure 
after the treatment of OSA with CPAP. 12 These paradoxical 
blood pressure responses occurred in 30 out of 508 patients 
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treated with CPAP, representing therefore 5.9 % of the 
population. The reasons for such fi ndings were not clear, 
particularly because compliance to CPAP therapy was 
good, and the authors were not able to find correlations 
between the rise in blood pressure and any variable such 
as the severity of sleep apnea. One possibility is that the 
authors made the option to focus on a subgroup of patients 
that presented a raise in BP. This phenomenon is known as 
regression to the mean, and is related to the fact that any 
variable that oscillates over time will present subgroups of 
patients that will oscillate to one direction, while others will 
present oscillations in the opposite direction. 13 It is possible 
therefore that in the subgroup of patients reported, CPAP 
treatment was coincidental and not related to the rise in 
blood pressure. It is also possible that the authors would 
have seen a significant fall in blood pressure after CPAP 
treatment if they had included all 508 patients treated with 
CPAP. This approach would reconcile the fi ndings of Loureiro 
et al. with the literature that has consistently shown a fall 
in blood pressure after the treatment of OSA with CPAP. On 
the other hand, this approach would still not answer the 
question of why a small proportion presents a paradoxical 
blood pressure response to CPAP therapy. Another possibility 
is that paradoxical BP responses after CPAP may be 
modulated by genetic factors, in a similar way to what 
has been reported with anti-hypertensive drugs. 14 Finally, 
another possibility is that in that 27 out of 30 patients were 
treated with automatic CPAP. At least one study showed that 
in contrast to fi xed CPAP, automatic CPAP was not able to 
decrease blood pressure nor markers of sympathetic activity 
in patients with OSA. 15 While, it is possible only to speculate 
why the paradoxical response occurred, this article sheds 
light on what is known as individualized medicine, that 
focuses on differences rather then similarities between 
patients. In conclusion, this issue of Portuguese Journal 
of Pulmonology contributes to the discussion of signifi cant 
aspects of OSA screening and complications. Moreover, it 
calls our attention to the importance of recognizing and 
treating patients with OSA.
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